<VariationArchive VariationID="985332" VariationName="NM_006186.4(NR4A2):c.325dup (p.Gln109fs)" VariationType="Duplication" Accession="VCV000985332" Version="10" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-01" DateCreated="2020-11-21" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="973244" VariationID="985332">
      <GeneList>
        <Gene Symbol="NR4A2" FullName="nuclear receptor subfamily 4 group A member 2" GeneID="4929" HGNC_ID="HGNC:7981" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="156324437" stop="156332721" display_start="156324437" display_stop="156332721" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="157180943" stop="157189286" display_start="157180943" display_stop="157189286" Strand="-" />
          </Location>
          <OMIM>601828</OMIM>
          <Haploinsufficiency last_evaluated="2022-09-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR4A2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-09-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR4A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006186.4(NR4A2):c.325dup (p.Gln109fs)</Name>
      <CanonicalSPDI>NC_000002.12:156329861:GGGGGGG:GGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="156329861" stop="156329862" display_start="156329861" display_stop="156329862" variantLength="1" positionVCF="156329861" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="157186373" stop="157186374" display_start="157186373" display_stop="157186374" variantLength="1" positionVCF="157186373" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>Q109fs</ProteinChange>
      <ProteinChange>Q46fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.157186380dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.157186380dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.156329868dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.156329868dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011821.1" sequenceAccession="NG_011821" sequenceVersion="1" change="g.7914dup">
            <Expression>NG_011821.1:g.7914dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006186.4" sequenceAccession="NM_006186" sequenceVersion="4" change="c.325dup" MANESelect="true">
            <Expression>NM_006186.4:c.325dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006177.1" sequenceAccession="NP_006177" sequenceVersion="1" change="p.Gln109fs">
            <Expression>NP_006177.1:p.Gln109fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173173.3" sequenceAccession="NM_173173" sequenceVersion="3" change="c.136dup">
            <Expression>NM_173173.3:c.136dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775265.1" sequenceAccession="NP_775265" sequenceVersion="1" change="p.Gln46fs">
            <Expression>NP_775265.1:p.Gln46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006186.3" sequenceAccession="NM_006186" sequenceVersion="3" change="c.325dup">
            <Expression>NM_006186.3:c.325dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601828.0006" DB="OMIM" />
        <XRef Type="rs" ID="774629025" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006186.4(NR4A2):c.325dup (p.Gln109fs) AND Inborn genetic diseases" Accession="RCV001266179" Version="4">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-01-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006186.4(NR4A2):c.325dup (p.Gln109fs) AND Neurodevelopmental disorder" Accession="RCV001724280" Version="2">
        <ClassifiedConditionList TraitSetID="37229">
          <ClassifiedCondition DB="MedGen" ID="C1535926">Neurodevelopmental disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006186.4(NR4A2):c.325dup (p.Gln109fs) AND not provided" Accession="RCV002275338" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006186.4(NR4A2):c.325dup (p.Gln109fs) AND Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism" Accession="RCV002260695" Version="1">
        <ClassifiedConditionList TraitSetID="76351">
          <ClassifiedCondition DB="MedGen" ID="C5677001">Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-06-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-12" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2020-11-21" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32366965</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="76351" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="62930" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism</ElementValue>
                <XRef ID="MONDO:0859257" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IDLDP</ElementValue>
                <XRef Type="MIM" ID="619911" DB="OMIM" />
              </Symbol>
              <XRef ID="C5677001" DB="MedGen" />
              <XRef ID="MONDO:0859257" DB="MONDO" />
              <XRef Type="MIM" ID="619911" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="37229" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38088" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder</ElementValue>
                <XRef ID="MONDO:0700092" DB="MONDO" />
              </Name>
              <XRef ID="C1535926" DB="MedGen" />
              <XRef ID="D065886" DB="MeSH" />
              <XRef ID="MONDO:0700092" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3831099" SubmissionDate="2021-12-28" DateLastUpdated="2022-01-01" DateCreated="2021-10-02">
        <ClinVarSubmissionID localKey="CVb_1076|MeSH:D065886" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001950012" DateUpdated="2022-01-01" DateCreated="2021-10-02" Type="SCV" Version="2" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was identified as de novo (maternity and paternity confirmed)._x000D_ Criteria applied: PVS1, PS2, PS4_SUP, PM2_SUP</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR4A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006186.4:c.325dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MeSH" ID="D065886" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10439859</SubmissionName>
          <SubmissionName>SUB10861288</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4970011" SubmissionDate="2022-06-22" DateLastUpdated="2022-07-08" DateCreated="2022-07-08">
        <ClinVarSubmissionID localKey="601828.0006_INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM" title="NR4A2, 1-BP DUP, 325C_INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM" />
        <ClinVarAccession Accession="SCV002540594" DateUpdated="2022-07-08" DateCreated="2022-07-08" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 2-year-old boy (patient 6) with intellectual developmental disorder with language impairment and early-onset dopa-responsive dystonia-parkinsonism (IDLDP; 619911), Singh et al. (2020) identified a de novo heterozygous 1-bp duplication (c.325dupC, NM_006186.3) in exon 3 of the NR4A2 gene, predicted to result in a frameshift and premature termination (Gln109ProfsTer3). The mutation, which was found by exome sequencing, was not present in the gnomAD database. Functional studies of the variant and studies of patient cells were not performed, but it was predicted to lead to nonsense-mediated mRNA decay and a loss of function with haploinsufficiency. The patient had a severe disorder with poor growth, global developmental delay, and abnormal eye movements apparent in early infancy. He developed focal seizures at age 6 months that progressed to infantile spasms and evolved to Lennox-Gastaut syndrome with refractory tonic and myoclonic seizures. Other features included hypotonia, disordered sleep, and feeding difficulties requiring tube feeding. Brain imaging showed pontine hypoplasia, enlarged ventricles, and delayed myelination.</Attribute>
              <Citation>
                <ID Source="PubMed">32366965</ID>
              </Citation>
              <XRef DB="OMIM" ID="619911" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR4A2" />
          </GeneList>
          <Name>NR4A2, 1-BP DUP, 325C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 325C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601828.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5011390" SubmissionDate="2023-11-22" DateLastUpdated="2023-11-25" DateCreated="2022-08-23">
        <ClinVarSubmissionID localKey="GDXSV:311883" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002562512" DateUpdated="2023-11-25" DateCreated="2022-08-23" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32366965)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR4A2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:4558325</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006186.3:c.325dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_124_20220817054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_236_20231122054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2852440" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2020-11-21">
        <ClinVarSubmissionID localKey="a6307893|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001444351" DateUpdated="2024-05-01" DateCreated="2020-11-21" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.325dupC (p.Q109Pfs*3) alteration, located in exon 3 (coding exon 1) of the NR4A2 gene, consists of a duplication of C at position 325, causing a translational frameshift with a predicted alternate stop codon after 3 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD) database, the NR4A2 c.325dupC alteration was observed in 0.0004% (1/250,966) of total alleles studied. Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR4A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006186.3:c.325dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5011390" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2852440" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3831099" TraitType="Disease" MappingType="XRef" MappingValue="D065886" MappingRef="MeSH">
        <MedGen CUI="C1535926" Name="Neurodevelopmental disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4970011" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM" MappingRef="Preferred">
        <MedGen CUI="C5677001" Name="Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

